Clinical trial
Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
NCT00273767 · University Hospital, Grenoble, Other · Completed
Key facts
| NCT number | NCT00273767 |
|---|---|
| Title | Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB |
| Official title | Double-blind Phase II Pilot Monocentric Randomized Clinical Trial Evaluating the Effect of a Preliminary Administration of Erythropoietin on Different Markers of Cardiac Ischemia Induced by Cardiopulmonary Bypass |
| Acronym | EPOetCEC |
| Lead sponsor | University Hospital, Grenoble, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Drug |
| Interventions | epoetin beta, placebo |
| Enrollment | 50 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 9, 2006 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: